These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
238 related articles for article (PubMed ID: 11718678)
1. Effect of mulberry (Morus indica L.) therapy on plasma and erythrocyte membrane lipids in patients with type 2 diabetes. Andallu B; Suryakantham V; Lakshmi Srikanthi B; Reddy GK Clin Chim Acta; 2001 Dec; 314(1-2):47-53. PubMed ID: 11718678 [TBL] [Abstract][Full Text] [Related]
2. Gluconeogenic substrates and hepatic gluconeogenic enzymes in streptozotocin-diabetic rats: effect of mulberry (Morus indica L.) leaves. Andallu B; Varadacharyulu NC J Med Food; 2007 Mar; 10(1):41-8. PubMed ID: 17472465 [TBL] [Abstract][Full Text] [Related]
3. Effects of acarbose versus glibenclamide on glycemic excursion and oxidative stress in type 2 diabetic patients inadequately controlled by metformin: a 24-week, randomized, open-label, parallel-group comparison. Wang JS; Lin SD; Lee WJ; Su SL; Lee IT; Tu ST; Tseng YH; Lin SY; Sheu WH Clin Ther; 2011 Dec; 33(12):1932-42. PubMed ID: 22078152 [TBL] [Abstract][Full Text] [Related]
4. Flavonoids extracted from mulberry (Morus alba L.) leaf improve skeletal muscle mitochondrial function by activating AMPK in type 2 diabetes. Meng Q; Qi X; Fu Y; Chen Q; Cheng P; Yu X; Sun X; Wu J; Li W; Zhang Q; Li Y; Wang A; Bian H J Ethnopharmacol; 2020 Feb; 248():112326. PubMed ID: 31639486 [TBL] [Abstract][Full Text] [Related]
5. Mulberry (Morus alba L.) Fruit Extract Containing Anthocyanins Improves Glycemic Control and Insulin Sensitivity via Activation of AMP-Activated Protein Kinase in Diabetic C57BL/Ksj-db/db Mice. Choi KH; Lee HA; Park MH; Han JS J Med Food; 2016 Aug; 19(8):737-45. PubMed ID: 27441957 [TBL] [Abstract][Full Text] [Related]
6. Insulin and sulfonylurea therapy in NIDDM patients. Are the effects on lipoprotein metabolism different even with similar blood glucose control? Romano G; Patti L; Innelli F; Di Marino L; Annuzzi G; Iavicoli M; Coronel GA; Riccardi G; Rivellese AA Diabetes; 1997 Oct; 46(10):1601-6. PubMed ID: 9313756 [TBL] [Abstract][Full Text] [Related]
7. Nateglinide and glibenclamide metabolic effects in naïve type 2 diabetic patients treated with metformin. Derosa G; D'Angelo A; Fogari E; Salvadeo S; Gravina A; Ferrari I; Cicero AF J Clin Pharm Ther; 2009 Feb; 34(1):13-23. PubMed ID: 19125899 [TBL] [Abstract][Full Text] [Related]
8. Antioxidant role of mulberry (Morus indica L. cv. Anantha) leaves in streptozotocin-diabetic rats. Andallu B; Varadacharyulu NCh Clin Chim Acta; 2003 Dec; 338(1-2):3-10. PubMed ID: 14637259 [TBL] [Abstract][Full Text] [Related]
9. Glibenclamide improves postprandial hypertriglyceridaemia in type 2 diabetic patients by reducing chylomicrons but not the very low-density lipoprotein subfraction levels. Skrapari I; Perrea D; Ioannidis I; Karabina SA; Elisaf M; Tselepis AD; Karagiannacos P; Katsilambros N Diabet Med; 2001 Oct; 18(10):781-5. PubMed ID: 11678967 [TBL] [Abstract][Full Text] [Related]
10. Lipid abnormalities in streptozotocin-diabetes: Amelioration by Morus indica L. cv Suguna leaves. Andallu B; Vinay Kumar AV; Varadacharyulu NCh Int J Diabetes Dev Ctries; 2009 Jul; 29(3):123-8. PubMed ID: 20165649 [TBL] [Abstract][Full Text] [Related]
11. Effects of white mulberry (Morus alba) leaf tea investigated in a type 2 diabetes model of rats. Wilson RD; Islam MS Acta Pol Pharm; 2015; 72(1):153-60. PubMed ID: 25850211 [TBL] [Abstract][Full Text] [Related]
12. Purification, characterization and anti-diabetic activity of a polysaccharide from mulberry leaf. Zhang Y; Ren C; Lu G; Cui W; Mu Z; Gao H; Wang Y Regul Toxicol Pharmacol; 2014 Dec; 70(3):687-95. PubMed ID: 25455227 [TBL] [Abstract][Full Text] [Related]
13. Chlorogenic acid and rutin play a major role in the in vivo anti-diabetic activity of Morus alba leaf extract on type II diabetic rats. Hunyadi A; Martins A; Hsieh TJ; Seres A; Zupkó I PLoS One; 2012; 7(11):e50619. PubMed ID: 23185641 [TBL] [Abstract][Full Text] [Related]
14. Lipid effects of glyburide/metformin tablets in patients with type 2 diabetes mellitus with poor glycemic control and dyslipidemia in an open-label extension study. Dailey GE; Mohideen P; Fiedorek FT Clin Ther; 2002 Sep; 24(9):1426-38. PubMed ID: 12380634 [TBL] [Abstract][Full Text] [Related]
15. Sustained effects of pioglitazone vs. glibenclamide on insulin sensitivity, glycaemic control, and lipid profiles in patients with Type 2 diabetes. Tan MH; Johns D; Strand J; Halse J; Madsbad S; Eriksson JW; Clausen J; Konkoy CS; Herz M; Diabet Med; 2004 Aug; 21(8):859-66. PubMed ID: 15270789 [TBL] [Abstract][Full Text] [Related]
16. Mulberry leaves ameliorate diabetes via regulating metabolic profiling and AGEs/RAGE and p38 MAPK/NF-κB pathway. Li JS; Ji T; Su SL; Zhu Y; Chen XL; Shang EX; Guo S; Qian DW; Duan JA J Ethnopharmacol; 2022 Jan; 283():114713. PubMed ID: 34626776 [TBL] [Abstract][Full Text] [Related]
17. A Blend of Sesame and Rice Bran Oils Lowers Hyperglycemia and Improves the Lipids. Devarajan S; Chatterjee B; Urata H; Zhang B; Ali A; Singh R; Ganapathy S Am J Med; 2016 Jul; 129(7):731-9. PubMed ID: 27046245 [TBL] [Abstract][Full Text] [Related]
18. The effects of metformin on glycemic control and serum lipids in insulin-treated NIDDM patients with suboptimal metabolic control. Robinson AC; Burke J; Robinson S; Johnston DG; Elkeles RS Diabetes Care; 1998 May; 21(5):701-5. PubMed ID: 9589227 [TBL] [Abstract][Full Text] [Related]
19. Effects of Juglans regia L. leaf extract on hyperglycemia and lipid profiles in type two diabetic patients: a randomized double-blind, placebo-controlled clinical trial. Hosseini S; Jamshidi L; Mehrzadi S; Mohammad K; Najmizadeh AR; Alimoradi H; Huseini HF J Ethnopharmacol; 2014 Mar; 152(3):451-6. PubMed ID: 24462785 [TBL] [Abstract][Full Text] [Related]